Clinical Trial Update: Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568] [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating simvastatin metabolism as a test for celiac disease activity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Entero Therapeutics | Conditions: Celiac Disease | EARLY_Phase 1 | Status: COMPLETED